27.06.2013 Views

GİRİŞ VE AMAÇ

GİRİŞ VE AMAÇ

GİRİŞ VE AMAÇ

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

EXPRESSION OF E-CADHERIN AND CD10 IN PROSTATIC<br />

ADENOCARCINOMAS<br />

SUMMARY<br />

Prostate cancer is the most common malignancy among men, with a higher<br />

incidence over the age of 50.<br />

The small size of material in needle biopsies used for diagnosis of the prostate<br />

cancer coupled with the detectability of increasingly higher number of welldifferentiated<br />

cancers by the help of new methods make it more difficult for a<br />

pathologist to establish a diagnosis of prostate cancer. In addition to routine methods,<br />

some supportive methods such as immunohistochemistry are required. The antibodies<br />

used in our study are E-cadherin and CD10.<br />

In our study, we examined 171 prostate biopsy materials sent to our Division<br />

between 1986 and 2005.<br />

Gleason grading was performed to determine the histological grade of the<br />

prostate adenocarcinomas, and Gleason scores of tumours were determined. The cases<br />

were stained with the antibodies, CD10 and E-cadherin. The studies with CD10, on the<br />

basis of each parameter of Gleason score, demonstrated no staining in the cases with<br />

Gleason score 2-4 (low grade). Staining was seen in the 8-10.5 % of the cases with<br />

Gleason score 5-7 (intermediate grade) and in the 89.5 - 92 % of the cases with<br />

Gleason score 8-10 (high score).<br />

In the studies with CD10, CD10 staining was not seen in prostate tumours with<br />

glandular pattern. However, it was seen in the solid prostate tumours and the prostate<br />

52

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!